WASF3 and breast cancer: Next we used both semi-quantitative RT-PCR (Figure 5B) and quantitative real-time-RT-PCR (Fig. 5C) to monitor the expression levels of WAVE3 in PBMC collected from ten patients with metastatic BC and ten healthy female controls with no known cancer history.